Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466884012 | Lanreotide 30mg injection (pdr)+diluent+syringe | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1457222017 | Lanreotide 30mg powder and solvent for injection suspension vial (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1477742014 | Lanreotide 30mg powder and solvent for injection suspension vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2695915018 | Lanreotide acetate 30mg/vial injection suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanreotide 30mg powder and solvent for injection suspension vial | Is a | Product containing lanreotide (medicinal product) | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Is a | Product containing somatostatin (medicinal product) | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has active ingredient | Lanreotide (substance) | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has active ingredient | Somatostatin | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has active ingredient | Lanreotide acetate (substance) | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Has active ingredient | Somatostatin | false | Inferred relationship | Some | ||
| Lanreotide 30mg powder and solvent for injection suspension vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR